Santo Domingo.- Pulmonology specialists warned that influenza A continues to be the respiratory virus highest incidence in the countryalmost entirely leading medical consultations for acute respiratory infections.
Evangelina Solerformer president of the Dominican Society of Pulmonology and Thorax Surgery, explained that in recent weeks there has been a predominant presence of influenza virus, especially type Awith few cases of influenza B.
He also indicated that the rhinovirus continues to circulate steadily, while cases of Covid-19 occur less frequently.
“Influenza A continues to lead respiratory consultations. We are also seeing rhinovirus and very few cases of Covid-19 at this time,” Soler said.
Increase in bacterial pneumonia in patients with respiratory diseases
The specialist added that, as is usual at this time of year, they are registering pneumonia caused by Haemophilus influenzaemainly in pneumopathic patientsthat is, people with chronic respiratory diseases.
Recent increase in influenza hospitalizations
While, Plutarco Ariaspast president of the specialized society, confirmed the high incidence of respiratory viruseshighlighting a dominant presence of influenza Awhile the influenza B and COVID-19 have been almost absent in recent weeks.
Arias warned that a significant number of patients have required hospital admission after complications due to influenzaespecially those with comorbidities or underlying diseasesas Asthma and Chronic Obstructive Pulmonary Disease (COPD).
“We are seeing severe symptoms, with intense bronchospasm and significant respiratory difficulty, especially in patients with chronic conditions,” explained the specialist.
The pulmonologist also reported that In the last two days there has been a considerable increase in patients affected by the influenza viruswhich keeps health services on alert.
The specialists reiterated the importance of maintain prevention measuresgo to a doctor early for respiratory symptoms and give special follow-up to the vulnerable groupssuch as older adults, patients with chronic diseases and immunocompromised people.
